Ferro-apoptosis in acute myeloid leukemia

Active Project Grant Awarded Last action

Award ID
HT9425261E471
Recipient
Awarding agency
Obligated
$1,399,826

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 3% complete
Place of performance
Houston, TX 77030, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Defense Health Agency awarded The University of Texas MD Anderson Cancer Center a project grant totaling $1,399,826 on September 30, 2026, under the Military Medical Research and Development program (CFDA 12.420) to support research on ferro-apoptosis in acute myeloid leukemia. Performance occurs in Houston, Texas, with a period of performance through September 29, 2029. The project grant is classified as assistance funding and represents part of the Defense Health Agency's portfolio of basic, applied, and advanced biomedical research aimed at transforming healthcare for Service Members and the American public through innovative medical solutions.

Quick answers

Who received award HT9425261E471?

HT9425261E471 was awarded to The Univeristy Of Texas M.d. Anderson Cancer Center by Defense Health Agency (Department of Defense) on September 30, 2026.

How much is award HT9425261E471 worth?

$1,399,826 has been obligated on HT9425261E471.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login